A university teaching lab depends on repeatability. When a demonstrator reconstitutes a lyophilised research peptide for an in-vitro practical, the record must let a colleague reproduce the preparation without guessing. This is not a clinical protocol: Research Sciences supplies research-use-only materials, and its products are not for human or veterinary use, consumption, administration or clinical application. The aim is a controlled laboratory workflow with traceable materials, calculations and observations.
Define the Reconstitution Record Before Anyone Opens a Vial
Start with a controlled document header, not a loose bench note. Include title, document number, version, effective date in month-and-year form, author, reviewer and a cross-reference to the relevant SOP. State the scope: in-vitro laboratory use only, with research-use-only materials that are not for human or veterinary use. Identify the teaching practical, the assay being supported, and the training required before a colleague performs the step. Link the record to the risk assessment and COSHH arrangements. This prevents a later reader from mistaking a teaching preparation for anything other than a controlled laboratory exercise.
Material identity deserves its own block. Record the product name, catalogue code, vial label reference and, where present, batch identifier or Internal Test Reference. Research Sciences labels vials in a reference format combining the SKU and expiry date, such as BPC10-03/27, and links supported products to corresponding CoAs. Exact purity, identity, storage advice and excipient information should be taken from the batch CoA and current published listing, not a previous year’s folder. If an Internal Test Reference is quoted, note that it links to sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Cap colour and packaging may vary and are not indicators of identity, analytical quality or manufacturing origin.
The pre-reconstitution state belongs in the record. Lyophilised research peptides are stored at –20°C or below, sealed with desiccant, protected from moisture, heat and light, and repeated freeze–thaw avoided. Require the vial and diluent to reach ambient temperature before opening and reconstitution in a research setting. Record bench location, pipettes and tips, diluent product and lot, and PPE. Note that only the amount required for the experiment should be removed from stock, so a colleague understands why a small working volume may be prepared.
Write the Step-by-Step Procedure So a Colleague Can Follow It Blind
Write the procedure as a sequence of observable actions with a decision point at each stage. Begin with the pre-use check: confirm the correct vial against the record, inspect the label, confirm the CoA is available, check that the diluent suits the in-vitro assay, and set the work area to the required cleanliness level. State how the vial is opened, how diluent is added, how the preparation is mixed and how complete dissolution is judged. Avoid shorthand only the author understands. Record what is actually done, including volume added, order of addition, mixing method, time and any visible change such as foaming, cloudiness or undissolved material.
Show the calculation, not just the final number. For an in-vitro stock, state the target concentration required by the assay, the stated vial content and the diluent volume to be added, using: diluent volume in millilitres equals peptide mass in milligrams divided by target concentration in milligrams per millilitre. Where a laboratory calculator is used, state that it is for laboratory research use only and not for human or veterinary dosing. Record the diluent exactly as supplied or prepared, for example the 10ml Mixing Water or Bacteriostatic Water wording in the current catalogue, with the lot number. If the preparation is not used immediately, specify the short-term laboratory storage condition and maximum period approved by the lab’s risk assessment.
Observation and deviation fields turn a recipe into a repeatable method. Leave space for actual diluent volume, preparation time, operator initials, reviewer initials and notes on anything that differed from plan. When replenishing teaching stocks, staff may review the supplier’s current research catalogue to Buy peptides and then check the batch-specific CoA, but the record should cite the exact product and CoA rather than a general order reference. If a step is changed after a trial run, mark the old version as superseded and state why. This matters when several demonstrators prepare the same stock across sessions; a clear deviation trail stops a workaround becoming an undocumented habit.
Build the Review, Storage and Handover Trail for Teaching Staff
A reconstitution record is only repeatable if someone other than its author has tested it. Arrange a dry run in which a colleague uses the document to identify the vial, locate the CoA, calculate the diluent volume and prepare a mock or non-critical preparation for the in-vitro teaching exercise. The reviewer should mark any point where they had to ask a question, guess a value or leave the bench for missing information. Resolve those queries in the next version, recording the reviewer’s name and the month-and-year date. Store the approved version in the shared teaching-lab system, not a personal notebook, and check that the version in use matches the practical schedule.
Post-reconstitution documentation should be equally specific. Label the prepared stock with product, calculated concentration, diluent, preparation date in the lab’s approved format, storage condition and operator initials. Reconstituted research peptides are less stable than lyophilised stock and should be held at 2–8°C for short-term laboratory use, with repeated freeze–thaw avoided. The record should say how surplus material and contaminated consumables are handled under COSHH and waste arrangements. Repeat the status clearly: these materials are not for human or veterinary use and are not medicines, supplements or clinical preparations. A colleague finding the record later should see what was prepared and why it remains inside the in-vitro workflow.
Handover notes should distinguish supplier documentation from laboratory interpretation. If Research Sciences is the chosen supplier, the record can note that the current site describes batch-level analytical verification and CoAs linked to supported products; the colleague should still open the CoA accompanying the specific batch and reconfirm published purity, storage and handling wording at the time of ordering. Treat published figures and delivery wording as current site text to be checked, not permanent specifications. Include the product page reference, CoA filename or location, and any Internal Test Reference. When the practical is repeated in a later semester, the new demonstrator can compare fresh batch documents against the teaching record, confirm the method still matches the assay, and prepare the same in-vitro stock without informal recollection. Research-use-only status, suitable storage and lawful disposal remain the laboratory’s responsibility, and the completed record is practical evidence that those checks were made.
